Insulin inhibits glucose production by a direct effect in diabetic depancreatized dogs during euglycemia. 2002

Neehar Gupta, and Harmanjit Sandhu, and Tracy Goh, and Keyur Shah, and Stephanie R Wiesenthal, and Hidenori Yoshii, and Victor Chong, and Tony K T Lam, and C Andrew Haber, and Wendy Williams, and Vaja Tchipashvili, and Adria Giacca
Department of Physiology, University of Toronto, Toronto, Ontario M5S 1A8, Canada.

In our previous studies in nondiabetic dogs and humans, insulin suppressed glucose production (GP) by both an indirect extrahepatic and a direct hepatic effect. However, insulin had no direct effect on GP in diabetic depancreatized dogs under conditions of moderate hyperglycemia. The present study was designed to investigate whether insulin can inhibit GP by a direct effect in this model under conditions of euglycemia. Depancreatized dogs were made euglycemic (approximately 6 mmol/l), rather than moderately hyperglycemic (approximately 10 mmol/l) as in our previous studies, by basal portal insulin infusion. After approximately 100 min of euglycemia, a hyperinsulinemic euglycemic clamp was performed by giving an additional infusion of insulin either portally (POR) or peripherally at about one-half the rate (1/2 PER) to match the peripheral venous insulin concentrations. The greater hepatic insulin load in POR resulted in greater suppression of GP (from 16.5 +/- 1.8 to 12.2 +/- 1.6 micromol. kg(-1). min(-1)) than 1/2 PER (from 17.8 +/- 1.9 to 15.6 +/- 2.0 micromol. kg(-1). min(-1), P < 0.001 vs. POR), consistent with insulin having a direct hepatic effect in suppressing GP. We conclude that the direct effect of insulin to inhibit GP is present in diabetic depancreatized dogs under conditions of acutely induced euglycemia. These results suggest that, in diabetes, the prevailing glycemic level is a determinant of the balance between insulin's direct and indirect effects on GP.

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D010179 Pancreas A nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion (EXOCRINE PANCREAS) is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the DUODENUM.
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005230 Fatty Acids, Nonesterified FATTY ACIDS found in the plasma that are complexed with SERUM ALBUMIN for transport. These fatty acids are not in glycerol ester form. Fatty Acids, Free,Free Fatty Acid,Free Fatty Acids,NEFA,Acid, Free Fatty,Acids, Free Fatty,Acids, Nonesterified Fatty,Fatty Acid, Free,Nonesterified Fatty Acids
D006943 Hyperglycemia Abnormally high BLOOD GLUCOSE level. Postprandial Hyperglycemia,Hyperglycemia, Postprandial,Hyperglycemias,Hyperglycemias, Postprandial,Postprandial Hyperglycemias

Related Publications

Neehar Gupta, and Harmanjit Sandhu, and Tracy Goh, and Keyur Shah, and Stephanie R Wiesenthal, and Hidenori Yoshii, and Victor Chong, and Tony K T Lam, and C Andrew Haber, and Wendy Williams, and Vaja Tchipashvili, and Adria Giacca
February 1999, Metabolism: clinical and experimental,
Neehar Gupta, and Harmanjit Sandhu, and Tracy Goh, and Keyur Shah, and Stephanie R Wiesenthal, and Hidenori Yoshii, and Victor Chong, and Tony K T Lam, and C Andrew Haber, and Wendy Williams, and Vaja Tchipashvili, and Adria Giacca
March 1997, Endocrinology,
Neehar Gupta, and Harmanjit Sandhu, and Tracy Goh, and Keyur Shah, and Stephanie R Wiesenthal, and Hidenori Yoshii, and Victor Chong, and Tony K T Lam, and C Andrew Haber, and Wendy Williams, and Vaja Tchipashvili, and Adria Giacca
November 1997, Diabetes,
Neehar Gupta, and Harmanjit Sandhu, and Tracy Goh, and Keyur Shah, and Stephanie R Wiesenthal, and Hidenori Yoshii, and Victor Chong, and Tony K T Lam, and C Andrew Haber, and Wendy Williams, and Vaja Tchipashvili, and Adria Giacca
November 1992, The Journal of clinical investigation,
Neehar Gupta, and Harmanjit Sandhu, and Tracy Goh, and Keyur Shah, and Stephanie R Wiesenthal, and Hidenori Yoshii, and Victor Chong, and Tony K T Lam, and C Andrew Haber, and Wendy Williams, and Vaja Tchipashvili, and Adria Giacca
January 1973, Surgical forum,
Neehar Gupta, and Harmanjit Sandhu, and Tracy Goh, and Keyur Shah, and Stephanie R Wiesenthal, and Hidenori Yoshii, and Victor Chong, and Tony K T Lam, and C Andrew Haber, and Wendy Williams, and Vaja Tchipashvili, and Adria Giacca
January 1976, Journal of surgical oncology,
Neehar Gupta, and Harmanjit Sandhu, and Tracy Goh, and Keyur Shah, and Stephanie R Wiesenthal, and Hidenori Yoshii, and Victor Chong, and Tony K T Lam, and C Andrew Haber, and Wendy Williams, and Vaja Tchipashvili, and Adria Giacca
May 1974, Diabetes,
Neehar Gupta, and Harmanjit Sandhu, and Tracy Goh, and Keyur Shah, and Stephanie R Wiesenthal, and Hidenori Yoshii, and Victor Chong, and Tony K T Lam, and C Andrew Haber, and Wendy Williams, and Vaja Tchipashvili, and Adria Giacca
July 1948, The American journal of physiology,
Neehar Gupta, and Harmanjit Sandhu, and Tracy Goh, and Keyur Shah, and Stephanie R Wiesenthal, and Hidenori Yoshii, and Victor Chong, and Tony K T Lam, and C Andrew Haber, and Wendy Williams, and Vaja Tchipashvili, and Adria Giacca
January 1990, Metabolism: clinical and experimental,
Neehar Gupta, and Harmanjit Sandhu, and Tracy Goh, and Keyur Shah, and Stephanie R Wiesenthal, and Hidenori Yoshii, and Victor Chong, and Tony K T Lam, and C Andrew Haber, and Wendy Williams, and Vaja Tchipashvili, and Adria Giacca
October 1984, Diabetes,
Copied contents to your clipboard!